Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ovarian Cancer, Epithelial
and you are
between 18 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

CHIMOVIP is a study to determine the best therapeutic strategy in patient with ovarian advanced cancer.

Provided treatments

  • Drug: CC0 - Carboplatin (IV) - Paclitaxel (IV)
  • Drug: CC0 - Cisplatin (IP) - Epirubicin (IV)
  • Drug: CC>0 - Carboplatin (IV)- Paclitaxel (IV)
  • Drug: CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03025477. The sponsor of the trial is Groupe Hospitalier Diaconesses Croix Saint-Simon and it is looking for 84 volunteers for the current phase.
Official trial title:
Randomized Study Assessing Two Strategies of First Line: a Strategy With Intraperitoneal Chemotherapy and a Strategy With Total Intravenous Strategy, in Patients With Epithelial Advanced Ovarian Cancer